Hasandalan, Irish .

HRN: 24-38-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2024
CEFUROXIME 1.5GM (VIAL)
01/13/2024
01/19/2024
IV
1.5g
On Call Or Then Q8
LTCs
Checking Final Appropriateness 
01/14/2024
CEFUROXIME 500MG (TAB)
01/14/2024
01/20/2024
PO
1tab
BID
Ltcs
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: